ashutosh kalbande

Contacter le RP

Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.

arrow_back

l’outil gratuit dédié aux journalistes
Ne subissez plus l’info, maîtrisez-la

Vous pouvez vous désinscrire gratuitement. Nous utiliserons les informations que vous nous avez fournies afin de vous transmettre des contenus ciblés comme décrit dans nos Règles de confidentialité.


En vous inscrivant, vous pourrez contacter des centaines de RP dont :

Vous pouvez vous désinscrire gratuitement. Nous utiliserons les informations que vous nous avez fournies afin de vous transmettre des contenus ciblés comme décrit dans nos Règles de confidentialité.

Caroline Grangie
Leboncoin
Responsable relation médias
Manon Guignard
Uber
Communication Associate
Sheherazade Renoux
PMU
Responsable communication

Pour en savoir plus, regardez la vidéo

Vous êtes à 1 clic de l'inscription !
Qu'est-ce que Babbler ?

Précédent

Content de vous revoir !

Communiqué de presse

Conjunctivitis Drugs Market to enroll appeal rate by 2022
timer minutes de lecture minute de lecture

Copier le lien
conjunctivitis-drugs-market-to-enroll-appeal-rate-by-2022

Cliquez sur l'image pour obtenir le format original

The report of Global Conjunctivitis Drugs Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in blurred vision. The viral and bacterial conjunctivitis results in highly infectious watery discharge which is extremely contagious.

The market for conjunctivitis is growing at a moderate rate. The growth factors for the  growth of global conjunctivitis drugs market are rise in hygiene and awareness, growing expenditure on health, greater exposure to allergens and infective agents, the contagious nature of the disease etc. However the market is restrained by many factors such as the self-limiting nature of the disease, off label drug use, greater fragmentation of the market and penetration of generics etc. However the most important reason is loss of patents on a number of market leaders such as Moxeza, Besivance, Vigamox, and Zymaxid. The lack of specific treatment for allergic conjunctivitis and self-limiting and non-life threatening nature of the treatment also acts as a constraint.

Taking all these factors together, we expect the Global Conjunctivitis Drugs Market to reach around US$ 1.08 billion by the end of the forecast period and is expected to grow at a CAGR of ~3.1%.

Key Players for Global Conjunctivitis Drugs Market:

Some of the key players in this market are: Akorn Pharmaceuticals, Alcon/ Novartis AG, Allergan Plc, Bausch & Lomb, Valeant Pharmaceuticals, Merck & Co. Inc., Actavis Plc., Pfizer Inc. and others.

Get Sample Copy at https://www.marketresearchfuture.com/sample_request/2513 .

Segments: 

Global conjunctivitis drugs market has been segmented on the basis of conjunctivitis type which comprises of viral, bacterial, allergic and others types of the same. On the basis of drug class; market is segmented into antibiotics (quinolones, aminoglycosides, macrolides and others), mast cell stabilizers, steroids and others. On the basis of route of administration; the market is segmented into topical, oral and intravitreal. On the basis of end users; market is segmented into hospitals and self-administered.

Regional Analysis of Global Conjunctivitis Drugs Market: 

Globally America is the largest market for conjunctivitis drugs followed by Europe. However both these markets are saturated and stagnant. The future growth will be ushered by Asia Pacific region closely followed by Middle East and African market. The growth will be largely led by unmet medical needs.

Table Of Contents

1 Introduction

2 Research Methodology

3 Market Dynamics

4 Market Factor Analysis

5 Global Conjunctivitis Drugs Market, By Conjunctivitis Type    

6 Global Conjunctivitis Drugs Market, By Drug Class

7 Global Conjunctivitis Drugs Market, By Route Of Administration

8 Global Conjunctivitis Drugs Market, By End Users

9 Global Conjunctivitis Drugs Market, By Regions

10 Company Landscape

11 Company Profile

12 Appendix

Access for Discount @ https://www.marketresearchfuture.com/check-discount/2513 .

Top Reasons to Buy the Reports:

  • Company profiling with detailed strategies, financials, and recent development activities 
  • Market Strategic Business Influence Data
  • Market Research Future recommendations in key business segments based on the market estimations 
  • Market share analysis of the top industry players 
  • Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

  • Fitness
  • Health & Medicine

Autres actualités de la marque

inscrit avec succès

Félicitations, vous êtes inscrit sur BABBLER !

Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !

Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici

  • Fitness
  • Health & Medicine